AU1670895A - Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker - Google Patents
Pharmaceutical product comprising a salicylate of an esterifiable beta-blockerInfo
- Publication number
- AU1670895A AU1670895A AU16708/95A AU1670895A AU1670895A AU 1670895 A AU1670895 A AU 1670895A AU 16708/95 A AU16708/95 A AU 16708/95A AU 1670895 A AU1670895 A AU 1670895A AU 1670895 A AU1670895 A AU 1670895A
- Authority
- AU
- Australia
- Prior art keywords
- esterifiable
- blocker
- salicylate
- beta
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002876 beta blocker Substances 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 title 1
- 229960001860 salicylate Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE940079 | 1994-01-28 | ||
| IE940079 | 1994-01-28 | ||
| PCT/IE1995/000011 WO1995020568A1 (en) | 1994-01-28 | 1995-01-27 | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1670895A true AU1670895A (en) | 1995-08-15 |
Family
ID=11040279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16708/95A Abandoned AU1670895A (en) | 1994-01-28 | 1995-01-27 | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0750608A1 (en) |
| JP (1) | JPH09508378A (en) |
| AU (1) | AU1670895A (en) |
| CA (1) | CA2182219A1 (en) |
| GB (1) | GB2300636A (en) |
| WO (1) | WO1995020568A1 (en) |
| ZA (1) | ZA95704B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228873B1 (en) | 1994-12-09 | 2001-05-08 | The Regents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| US5763491A (en) * | 1994-12-09 | 1998-06-09 | The Regents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| WO1997005128A1 (en) * | 1995-07-27 | 1997-02-13 | Cal International Limited | Cardioactive aspirinates |
| DE19743143A1 (en) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Combination pharmaceutical preparations |
| RU2256447C1 (en) * | 2004-01-30 | 2005-07-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Pharmaceutical composition with cardioselective beta-adrenergic antagonist (variants) |
| JP5092940B2 (en) * | 2008-07-01 | 2012-12-05 | 信越半導体株式会社 | Single crystal manufacturing apparatus and single crystal manufacturing method |
| CN116178161A (en) * | 2023-03-13 | 2023-05-30 | 甘肃泰友生物科技有限公司 | Method for accurately synthesizing aspirin series polymeric impurities |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2635209C2 (en) * | 1975-08-15 | 1983-01-27 | Sandoz-Patent-GmbH, 7850 Lörrach | 4- (2-Benzoyloxy-3-tert-butylamino-propoxy) -2-methylindole, its (S) -enantiomer, their acid addition salts, processes for their preparation and medicaments containing these compounds |
| WO1988007044A1 (en) * | 1987-03-17 | 1988-09-22 | Insite Vision, Inc. | Timolol derivatives |
| IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
-
1995
- 1995-01-27 CA CA002182219A patent/CA2182219A1/en not_active Abandoned
- 1995-01-27 EP EP95908363A patent/EP0750608A1/en not_active Withdrawn
- 1995-01-27 GB GB9616298A patent/GB2300636A/en not_active Withdrawn
- 1995-01-27 WO PCT/IE1995/000011 patent/WO1995020568A1/en not_active Ceased
- 1995-01-27 JP JP7519968A patent/JPH09508378A/en active Pending
- 1995-01-27 AU AU16708/95A patent/AU1670895A/en not_active Abandoned
- 1995-01-30 ZA ZA95704A patent/ZA95704B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2182219A1 (en) | 1995-08-03 |
| MX9603034A (en) | 1998-05-31 |
| WO1995020568A1 (en) | 1995-08-03 |
| ZA95704B (en) | 1995-10-25 |
| GB9616298D0 (en) | 1996-09-11 |
| EP0750608A1 (en) | 1997-01-02 |
| JPH09508378A (en) | 1997-08-26 |
| GB2300636A (en) | 1996-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3173095A (en) | Novel pharmaceutical product | |
| AU9310898A (en) | Marking of orally ingested products | |
| AU5511998A (en) | Ultrasonic forming of confectionery products | |
| AU7186696A (en) | Confectionery product | |
| ZA957753B (en) | Novel pharmaceutical product | |
| AU6973396A (en) | Pharmaceutical formulation | |
| AU6904896A (en) | Pharmaceutical compounds | |
| AU2289195A (en) | Aglyco products | |
| AU7186796A (en) | Chocolate products | |
| AU6941896A (en) | Packaging and display unit for products | |
| AU1670895A (en) | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker | |
| GB9411388D0 (en) | Pharmaceutical products | |
| AU7582696A (en) | Pharmaceutical formulation | |
| AU5497796A (en) | New hydroximic acid derivatives | |
| AU6305896A (en) | Terpene-based pharmaceutical product | |
| AU9358498A (en) | Closures for pressurised products | |
| AU665073B2 (en) | Novel thiosemicarbazone derivatives | |
| AU1670995A (en) | A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor | |
| AU3949093A (en) | A pharmaceutical formulation | |
| AU3659693A (en) | Multiple package for pharmaceutical products | |
| AU4379893A (en) | Oral decongestant product | |
| AU7551896A (en) | 1-azabicycloheptane derivatives and their pharmaceutical use | |
| AU7546096A (en) | Pharmaceutical compounds | |
| AU4612393A (en) | Improved tubular casing for food products | |
| AU126984S (en) | Pharmaceutical product |